According to Pacific Biosciences 's latest financial reports the company's current revenue (TTM) is $0.20 B. In 2022 the company made a revenue of $0.12 B a decrease over the years 2021 revenue that were of $0.13 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.20 B | 56.29% |
2022 | $0.12 B | -1.69% |
2021 | $0.13 B | 65.43% |
2020 | $78.89 M | -13.2% |
2019 | $90.89 M | 15.6% |
2018 | $78.62 M | -15.88% |
2017 | $93.46 M | 3.04% |
2016 | $90.71 M | -2.23% |
2015 | $92.78 M | 53.12% |
2014 | $60.59 M | 115.02% |
2013 | $28.18 M | 8.46% |
2012 | $25.98 M | -23.27% |
2011 | $33.86 M | 1922.88% |
2010 | $1.67 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $42.85 B | 21,272.82% | ๐บ๐ธ USA |
General Electric GE | $67.95 B | 33,787.72% | ๐บ๐ธ USA |
Illumina ILMN | $4.50 B | 2,146.15% | ๐บ๐ธ USA |
PerkinElmer
PKI | $3.35 B | 1,574.36% | ๐บ๐ธ USA |
Luminex LMNX | N/A | N/A | ๐บ๐ธ USA |
NanoString Technologies NSTG | $0.16 B | -18.97% | ๐บ๐ธ USA |